NO326057B1 - Antitrombotiske forbindelser samt anvendelse derav og farmasoytisk sammensetning. - Google Patents

Antitrombotiske forbindelser samt anvendelse derav og farmasoytisk sammensetning. Download PDF

Info

Publication number
NO326057B1
NO326057B1 NO20006317A NO20006317A NO326057B1 NO 326057 B1 NO326057 B1 NO 326057B1 NO 20006317 A NO20006317 A NO 20006317A NO 20006317 A NO20006317 A NO 20006317A NO 326057 B1 NO326057 B1 NO 326057B1
Authority
NO
Norway
Prior art keywords
compound according
alkyl
group
compound
mmol
Prior art date
Application number
NO20006317A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006317D0 (no
NO20006317L (no
Inventor
Constant Adriaan Anton Van Boeckel
Johannes Egbertus Maria Basten
Cornelia Maria Dreef-Tromp
Rogier Christian Buijsman
Original Assignee
Univ Leiden
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leiden, Akzo Nobel Nv filed Critical Univ Leiden
Publication of NO20006317D0 publication Critical patent/NO20006317D0/no
Publication of NO20006317L publication Critical patent/NO20006317L/no
Publication of NO326057B1 publication Critical patent/NO326057B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20006317A 1998-06-17 2000-12-12 Antitrombotiske forbindelser samt anvendelse derav og farmasoytisk sammensetning. NO326057B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202037 1998-06-17
PCT/EP1999/004100 WO1999065934A1 (en) 1998-06-17 1999-06-11 Antithrombotic compounds

Publications (3)

Publication Number Publication Date
NO20006317D0 NO20006317D0 (no) 2000-12-12
NO20006317L NO20006317L (no) 2001-02-14
NO326057B1 true NO326057B1 (no) 2008-09-08

Family

ID=8233825

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006317A NO326057B1 (no) 1998-06-17 2000-12-12 Antitrombotiske forbindelser samt anvendelse derav og farmasoytisk sammensetning.

Country Status (31)

Country Link
US (1) US6486129B1 (cs)
EP (1) EP1087992B1 (cs)
JP (1) JP4369052B2 (cs)
KR (1) KR100790910B1 (cs)
CN (1) CN1261450C (cs)
AR (1) AR019674A1 (cs)
AT (1) ATE405580T1 (cs)
AU (1) AU756493B2 (cs)
BR (1) BR9911300A (cs)
CA (1) CA2334863C (cs)
CO (1) CO5080750A1 (cs)
CY (1) CY1108567T1 (cs)
CZ (1) CZ299382B6 (cs)
DE (1) DE69939378D1 (cs)
DK (1) DK1087992T3 (cs)
ES (1) ES2312210T3 (cs)
HK (1) HK1034266A1 (cs)
HU (1) HU229088B1 (cs)
ID (1) ID26614A (cs)
IL (2) IL139955A0 (cs)
NO (1) NO326057B1 (cs)
NZ (1) NZ508623A (cs)
PE (1) PE20000700A1 (cs)
PL (1) PL199433B1 (cs)
PT (1) PT1087992E (cs)
RU (1) RU2225869C2 (cs)
SK (1) SK286755B6 (cs)
TR (1) TR200003710T2 (cs)
TW (1) TWI221156B (cs)
WO (1) WO1999065934A1 (cs)
ZA (1) ZA200007075B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2312210T3 (es) * 1998-06-17 2009-02-16 N.V. Organon Composiciones antitromboticas.
TWI289566B (en) * 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
DE10049937A1 (de) * 2000-10-06 2002-04-11 Knoll Ag Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten
KR20040096541A (ko) * 2002-01-31 2004-11-16 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 인자 Xa 활성을 저해하는 화합물
DE10300049A1 (de) * 2003-01-03 2004-07-15 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Faktor VIIa inhibieren
DE10330900B4 (de) * 2003-07-01 2006-09-14 Leibniz-Institut Für Polymerforschung Dresden E.V. Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
CN101312747B (zh) * 2005-10-10 2013-03-20 Msd欧斯股份有限公司 包括生物素标记的抗血栓形成双重抑制剂
US20090111769A1 (en) * 2005-10-10 2009-04-30 De Kort Martin Antithrombotic Compound
EP2421878B1 (en) * 2008-10-03 2017-06-14 Glycan Biosciences LLC Anionic oligosaccharide conjugates
US20220380478A1 (en) 2019-07-01 2022-12-01 Tonix Pharma Holdings Limited Anti-cd154 antibodies and uses thereof
MX2023008055A (es) 2021-01-06 2023-08-22 Tonix Pharma Ltd Métodos para inducir tolerancia inmune con anticuerpos anti-cd154 modificados.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84170B (pt) 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
DE4115468A1 (de) 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
ES2147216T3 (es) * 1993-09-01 2000-09-01 Akzo Nobel Nv Bisconjugados que comprenden dos sacaridos y un grupo de union.
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
ES2312210T3 (es) * 1998-06-17 2009-02-16 N.V. Organon Composiciones antitromboticas.

Also Published As

Publication number Publication date
PL199433B1 (pl) 2008-09-30
HU229088B1 (en) 2013-07-29
CO5080750A1 (es) 2001-09-25
CA2334863A1 (en) 1999-12-23
NO20006317D0 (no) 2000-12-12
PL345238A1 (en) 2001-12-03
AU756493B2 (en) 2003-01-16
CN1305494A (zh) 2001-07-25
KR20010052943A (ko) 2001-06-25
EP1087992A1 (en) 2001-04-04
NZ508623A (en) 2002-11-26
RU2225869C2 (ru) 2004-03-20
TWI221156B (en) 2004-09-21
HUP0102764A3 (en) 2003-11-28
AU4512999A (en) 2000-01-05
EP1087992B1 (en) 2008-08-20
PT1087992E (pt) 2008-10-17
KR100790910B1 (ko) 2008-01-03
HK1034266A1 (en) 2001-10-19
WO1999065934A1 (en) 1999-12-23
CY1108567T1 (el) 2014-04-09
DK1087992T3 (da) 2008-11-24
SK286755B6 (sk) 2009-05-07
JP4369052B2 (ja) 2009-11-18
US6486129B1 (en) 2002-11-26
IL139955A (en) 2006-08-20
CZ299382B6 (cs) 2008-07-09
PE20000700A1 (es) 2000-08-14
HUP0102764A2 (hu) 2001-12-28
ID26614A (id) 2001-01-25
NO20006317L (no) 2001-02-14
DE69939378D1 (de) 2008-10-02
TR200003710T2 (tr) 2001-04-20
IL139955A0 (en) 2002-02-10
ES2312210T3 (es) 2009-02-16
JP2002518407A (ja) 2002-06-25
BR9911300A (pt) 2001-04-03
CZ20004735A3 (cs) 2001-08-15
ZA200007075B (en) 2002-02-28
ATE405580T1 (de) 2008-09-15
SK19222000A3 (sk) 2001-07-10
AR019674A1 (es) 2002-03-13
CA2334863C (en) 2011-02-15
CN1261450C (zh) 2006-06-28

Similar Documents

Publication Publication Date Title
US6486129B1 (en) Antithrombotic compounds
JP5632886B2 (ja) ビオチン残基を含む抗血栓性デュアルインヒビター
JP4820517B2 (ja) 抗血栓性化合物
MXPA00012554A (en) Antithrombotic compounds
MXPA02005278A (en) Antithrombotic compound

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: UNIVERSITEIT LEIDEN, NL

MM1K Lapsed by not paying the annual fees